adMare BioInnovations
Edit

adMare BioInnovations

https://www.admarebio.com
Last activity: 17.10.2023
Invests in categories: DrugInformationDevelopmentBioTechMedTechTechnologyProductHardwareHealthTechPlatform
About adMare BioInnovations With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To make this a reality, adMare uses its scientific and commercial expertise, specialized infrastructure, and investment capital to build new companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term. Our 25+ portfolio companies have attracted more than $1.4 billion of investment, have a combined value of over $3 billion, and employ more than 900 Canadians. Our Innovation Centres are home to 35+ biotech companies, contract research organizations, and specialized commercialization support organizations. The adMare Academy has trained more than 500 alumni – 95% of whom are now working to build our life sciences industry. À propos d’adMare BioInnovations Grâce à la richesse de ses découvertes scientifiques, le Canada est prêt à devenir un leader mondial dans le secteur des sciences de la vie. Pour concrétiser cette vision, adMare utilise son expertise scientifique et commerciale, son infrastructure spécialisée et son capital d’investissement pour créer de nouvelles entreprises solides, des écosystèmes robustes et des talents prêts pour l’industrie - et réinvestit ses bénéfices dans l’industrie canadienne pour s’assurer qu’elle est soutenue à long terme. Nos 25+ entreprises en portefeuille ont su attirer plus de 1,4 milliard de dollars d'investissements, ont une valeur combinée de plus de 3 milliards de dollars et emploient plus de 900 Canadiens. Nos centres d'innovation soutiennetla croissance de 35+ entreprise résidentes canadiennes en sciences de la vie. L'Académie adMare a formé plus de 500 anciens étudiants, dont 95 % travaillent dans le secteur canadien des sciences de la vie.
News
97
Portfolio
24
Mentions
8
Location: Canada, British Columbia, Vancouver
Employees: 51-200
Founded date: 2019

Portfolio 24

DateNameWebsiteTotal RaisedLocation
10.05.2022Domain The...domainther...$55.27MFrance, Gr...
23.02.2022ImStar The...arnatherap...--
07.07.2021NIMIUM THE...nimium.ca--
-Flosonics ...flosonicsm...$19MCanada, On...
-PrecisionN...precisionn...$31.6MCanada, Br...
-viDA Thera...can01.safe...--
-ImStar The...imstartx.c...-Canada, Br...
-Forus Ther...forusthera...--
-Zucarazucara.ca$25.25M-
-Inversago ...inversago....$137M-
Show more

News 97

DateTitleDescription
18.05.2022adMare Appoints Dr. Christine Allen as Vice-President, Ecosy...Toronto May 18, 2022 – adMare BioInnovations is pleased to announce the appointment of Dr. Christine...
10.05.2022adMare BioInnovations joins a $42m Series A financing in Dom...Strasbourg, France – Montreal, Canada – May 10, 2022 – Domain Therapeutics, a biopharmaceutical comp...
03.05.2022adMare BioInnovations Collaborates with Accelerator Company,...MONTREAL, QUEBEC, April 5, 2022 – Molecular Forecaster Inc. (MFI) is excited to announce a partnersh...
02.05.2022adMare Portfolio Company, Zucara Therapeutics Secures Additi...Toronto, Canada, May 2, 2022 – Zucara Therapeutics Inc., a diabetes life sciences company developing...
15.04.2022Read the newest issue of the adMare Quarterly newsletter – A...adMare Quarterly It has been a busy few months at adMare! From a transformative investment of $92M r...
08.04.2022Building Canada’s Life Sciences Industry on a Strong Foundat...Labour shortages are hitting virtually every Canadian sector, from coffee shops to car manufacturing...
30.03.2022Government of Canada Invests $92 million in adMare to help t...GOVERNMENT OF CANADA RELEASE Government of Canada advances domestic life sciences sector by support...
16.03.2022Listen to adMare’s President & CEO, Gordon C. McCauley o...adMare’s President & CEO, Gordon C. McCauley speaks with Dr. Naveed Aziz on the first episode of...
14.03.2022Join Us For adMare’s Global Leaders Webinar Featuring Dr. Ro...adMare Global Leaders Webinar From Lab bench to clinic: How to solve global health challenges by de...
11.03.2022adMare supports Ukraine; Responds to Ministers Champagne and...Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and...
Show more

Mentions in press and media 8

DateTitleDescriptionSource
17.10.2023Specific Biologics Announces Additional Investment and Appoi...Specific Biologics Inc. (“Specific”), a venture-backed, early-stage genome editing company, is pleas...lumiravent...
20.04.2023Cancer Biotech Abdera Reveals $142M for Better Antibody-Base...Less than three years ago, a group of Canadian scientists got together to brainstorm a better radiop...medcitynew...
10.05.2022adMare BioInnovations joins a $42m Series A financing in Dom...Strasbourg, France – Montreal, Canada – May 10, 2022 – Domain Therapeutics, a biopharmaceutical comp...admarebio....
03.04.2022💯 Thinkers for hireGood morning and welcome to the Sunday Briefing. I’m back, and so are in-person events, so I’d like ...vantechjou...
20.04.2021Cheatsheet: Top 30 highlights for innovators in #Budget2021Today the federal government released Budget 2021: A Recovery Plan for Jobs, Growth, and Resilience....vantechjou...
18.04.2021Meet the Vancouver investor who bet on Coinbase—and scored a...Good afternoon and welcome to the hundreds of new Vancouver Tech Journal subscribers reading this Su...vantechjou...
31.03.2020Zucara Therapeutics, an adMare & TIAP Spin-off Company, ...Toronto, Canada – Zucara Therapeutics Inc., a diabetes life sciences company developing the first on...admarebio....
03.12.2019Bright Angel Therapeutics Announces New Funding to Advance T...TORONTO – Bright Angel Therapeutics, a biotechnology company focused on developing novel antifungal ...lumiravent...

Reviews 0

Sign up to leave a review

Sign up Log In